AMSilk Enters its Industrialisation Phase
AMSilk is the world’s first industrial supplier of vegan silk biopolymers that are biodegradable, recyclable, renewable and zero-waste.
Destiny Pharma’s microbiome project for Clostridioides difficile infection
Destiny Pharma CEO, Neil Clark interviewed by Amy Brown at Evaluate Vantage
The promise of mRNA therapeutics in producing the first regenerative treatment for SUI
Article by Dr Roger Dmochowski, Professor of Urology & Advisory Board Member of Versameb
Optimum Celebrates International Women’s Day 2022
In the spirit of spreading the message on sustainability, especially throughout the healthcare industry, Optimum decided to celebrate International Women’s Day 2022 by asking the brilliant women in healthcare what the subject of ESG means to them.
What Next After A Year Of Innovation And Growth?
As part of its ‘Pharma Outlook for 2022’, leading healthcare publication, In Vivo, explored the outlook for US and EU venture capital funding in biopharma. Asking whether the sector can keep the momentum going for investments, it drew on the experience and insight of prominent investors [many among them our clients,] to provide comment on […]
